Abiopharma

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights

KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada

Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection

XORTX Announces USD $925,000 Private Placement

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025